Top Markets
Coin of the day
Adynxx, Inc. Adynxx, Inc.

Adynxx, Inc.

ADYX
Rank in Stocks #42632
Adynxx, Inc. is a clinical-stage biopharmaceutical firm dedicated to creating... Adynxx, Inc. is a clinical-stage biopharmaceutical firm dedicated to creating and commercializing novel transcription factor decoy technologies to combat pain and inflammatory conditions. Central to its efforts is the AYX platform of transcription factor decoys, which includes brivoligide, currently progressing through Phase II clinical development for reducing post-surgical discomfort. Additionally, AYX2 is a pre-clinical candidate being explored for its potential in treating localized chronic pain. Established in 2007, the company's corporate headquarters are situated in San Francisco, California.
Share Price
$0.0001
Last synced: 2026-08-11
Market Cap
$581.00
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Adynxx, Inc. (ADYX)

Category

Price of ADYX with the market cap of B
Adynxx, Inc. Adynxx, Inc.
ADYX
$0.0001
Market Capitalization of Adynxx, Inc.(ADYX)
Market Cap: $581.00
As of August 2026 Adynxx, Inc. has a market cap of $581.00. This makes Adynxx, Inc. the world's 42632nd most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Adynxx, Inc. from 1998 to 2026
ADYX compared with Top 5 Most Popular stocks
Price of ADYX Asset B Mkt. of B Results
Adynxx, Inc. Adynxx, Inc.
$933,905 $581.00
$5.426T +933,905,081,394.49%
Adynxx, Inc. Adynxx, Inc.
$761,948 $581.00
$4.427T +761,947,671,493.80%
Adynxx, Inc. Adynxx, Inc.
$712,384 $581.00
$4.139T +712,383,740,219.28%
Adynxx, Inc. Adynxx, Inc.
$629,267 $581.00
$3.656T +629,267,416,290.19%
Adynxx, Inc. Adynxx, Inc.
$496,669 $581.00
$2.886T +496,668,822,705.51%